Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.
about
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerChallenges in Antibody Development against Tn and Sialyl-Tn AntigensGlycosylation of uroplakins. Implications for bladder physiopathologyThe Role of Sialyl-Tn in CancerP53 and cancer-associated sialylated glycans are surrogate markers of cancerization of the bladder associated with Schistosoma haematobium infection.Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery.Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapyHypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer.Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against CancerSilencing of ST6GalNAc I suppresses the proliferation, migration and invasion of hepatocarcinoma cells through PI3K/AKT/NF-κB pathway.A glycoproteomic approach to identify novel glycomarkers for cancer stem cells.Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage.Different expression levels of glycans on leukemic cells-a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid.Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation and ERK1/2 and p38 MAPK activation.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium.ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma.Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids
P2860
Q26751472-1ABD5910-2014-4F4B-A200-0A726A3F21DEQ26798183-3DB10E00-F360-4AC2-B401-ECC99574E0DFQ26823952-15E64B1E-316A-46D4-B50D-ED82831C4145Q28075448-001C7C9D-A5AF-447A-9146-3659CDBD233CQ34680930-D6BBC69C-8B7C-479F-9645-1E70FD8EEA7EQ35692128-20BF9CAA-0184-4F7F-99C9-62BBEB356476Q35841848-2C61DACF-B079-4009-B4B2-40781BE3D921Q37235573-34CE5907-40F7-4B77-8802-C83D1B5EE8E8Q37665276-216038A4-61BD-4230-A185-A3892C4AF5B4Q37696344-B9C258A0-A8A0-4309-A3FD-B2A07F80DFDCQ38544783-6B225D24-6CED-426C-A5D0-AEBD318C5933Q38737068-99F5A6F1-B93C-401B-8B78-CEBDD06F025EQ38763337-88C3FB4F-5523-49DE-B55F-D5D5A299EF1AQ39013095-09E74F7B-EF6A-4B6E-90F8-43C3225B4871Q41194359-C3E4F0C6-216E-4A7B-B6CD-27A7236784E6Q41551732-ECCA61E4-CA6C-4F91-80BA-FF228D67B3BAQ41680595-E86EB3A4-6361-476F-AF1F-7D4D97B51FA1Q47272986-E63A1F47-47FB-4686-AB59-520E89F0C5F2Q47281580-F69C8A80-8554-425F-87A1-BF0C8D0E89C3Q47301558-DB08BBBC-158A-420C-92D9-606FEEDD8200Q49179521-D1C857DF-6D4F-4B6E-8392-BB40BE9D406DQ49293633-A8E14106-BCAC-41CF-8860-50CEA7303502Q49901112-2EA0B4D6-A2F1-4D6F-8714-D04F39FB92F7Q55515607-24B3D27A-7F5C-4624-876A-E19F90769FEDQ57169347-931D9E14-AB68-48AF-AD10-FC60BC4B9675
P2860
Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Overexpression of tumour-assoc ...... n in advanced bladder tumours.
@en
Overexpression of tumour-assoc ...... n in advanced bladder tumours.
@nl
type
label
Overexpression of tumour-assoc ...... n in advanced bladder tumours.
@en
Overexpression of tumour-assoc ...... n in advanced bladder tumours.
@nl
prefLabel
Overexpression of tumour-assoc ...... n in advanced bladder tumours.
@en
Overexpression of tumour-assoc ...... n in advanced bladder tumours.
@nl
P2093
P2860
P1433
P1476
Overexpression of tumour-assoc ...... n in advanced bladder tumours.
@en
P2093
Andreia Almeida
Elisabete Fernandes
Fabio Dall'Olio
Francisco Amado
José Alexandre Ferreira
Lúcio Lara Santos
Maria J Oliveira
Mariana Silva
P2860
P304
P356
10.1016/J.MOLONC.2013.03.001
P577
2013-03-21T00:00:00Z